{"schemaVersion":"peptidescanner-evidence-bundle/v1","canonicalUrl":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json","manifestUrl":"https://peptidescanner.com/evidence/v1/manifest.json","peptide":{"slug":"gallium-ga-68-dotatate","name":"Gallium Ga 68 dotatate","url":"https://peptidescanner.com/peptides/gallium-ga-68-dotatate/"},"addressing":"objects is keyed by objectPathId. A URL fragment #<objectPathId> on this file names one evidence object. Every version of a record is placed in the bundle of the record's current first peptide.","objectCount":13,"objects":{"clinicaltrials-gov-nct03206060-gallium-ga-68-dotatate-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03206060-gallium-ga-68-dotatate:v1","objectPathId":"clinicaltrials-gov-nct03206060-gallium-ga-68-dotatate-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03206060-gallium-ga-68-dotatate/","json":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#clinicaltrials-gov-nct03206060-gallium-ga-68-dotatate-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.md#clinicaltrials-gov-nct03206060-gallium-ga-68-dotatate-v1"},"story":{"slug":"clinicaltrials-gov-nct03206060-gallium-ga-68-dotatate","version":1,"domain":"Clinical trials","dateInSource":"2026-10-26","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["gallium-ga-68-dotatate"],"peptides":[{"slug":"gallium-ga-68-dotatate","url":"https://peptidescanner.com/peptides/gallium-ga-68-dotatate/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03206060","sourceIds":["ctg-observation-nct03206060-2026-10-26-49cf7f72ecf5"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03206060 at 2026-11-16T17:36:42.191Z. Its registry update date was 2026-10-26, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.","sourceIds":["ctg-observation-nct03206060-2026-10-26-49cf7f72ecf5"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03206060 at 2026-11-16T17:36:42.191Z. Its registry update date was 2026-10-26, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.","sourceIds":["ctg-observation-nct03206060-2026-10-26-49cf7f72ecf5"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03206060-2026-10-26-49cf7f72ecf5"]}],"sources":[{"id":"ctg-observation-nct03206060-2026-10-26-49cf7f72ecf5","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03206060 · retained source version 2026-10-26:49cf7f72ecf561f74f8563b59065799bc0a357fb6e3636666768d5d28d96190c","url":"https://clinicaltrials.gov/study/NCT03206060"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"9f8be3d97e662fafb3448f0e09e5129e613d452246c1aa009bf1514e62a10868","tierARecordSha256":"32a55b71bb95175489ef0ea70041832953321b5eea06b7b173c52a2e3a16dc1d"},"integrity":{"algorithm":"sha256","contentSha256":"0e2e3b4795f279087fbba952b3a0e780967f98f058671df8658891e6a6d0b93a"}},"clinicaltrials-gov-nct03448458-gallium-ga-68-dotatate-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03448458-gallium-ga-68-dotatate:v1","objectPathId":"clinicaltrials-gov-nct03448458-gallium-ga-68-dotatate-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03448458-gallium-ga-68-dotatate/","json":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#clinicaltrials-gov-nct03448458-gallium-ga-68-dotatate-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.md#clinicaltrials-gov-nct03448458-gallium-ga-68-dotatate-v1"},"story":{"slug":"clinicaltrials-gov-nct03448458-gallium-ga-68-dotatate","version":1,"domain":"Clinical trials","dateInSource":"2025-07-17","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["gallium-ga-68-dotatate"],"peptides":[{"slug":"gallium-ga-68-dotatate","url":"https://peptidescanner.com/peptides/gallium-ga-68-dotatate/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03448458","sourceIds":["ctg-observation-nct03448458-2025-07-17-80a925d78e44"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03448458 at 2026-11-16T17:36:42.191Z. Its registry update date was 2025-07-17, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.","sourceIds":["ctg-observation-nct03448458-2025-07-17-80a925d78e44"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03448458 at 2026-11-16T17:36:42.191Z. Its registry update date was 2025-07-17, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.","sourceIds":["ctg-observation-nct03448458-2025-07-17-80a925d78e44"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03448458-2025-07-17-80a925d78e44"]}],"sources":[{"id":"ctg-observation-nct03448458-2025-07-17-80a925d78e44","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03448458 · retained source version 2025-07-17:80a925d78e44e87a1a539fa3eb17f6b22b5f19adb2092ca016e108ee9e9497f7","url":"https://clinicaltrials.gov/study/NCT03448458"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c2736c64883f1401c24d67cb1a9b9dc4a320850fcf04fe84b4ab4cc1474c5fb0","tierARecordSha256":"0cee6b5458001664dae9264fde2934309d122b8af66fca066c565db6035a9466"},"integrity":{"algorithm":"sha256","contentSha256":"2c0f4132fe7a797a2acb297410432d5c23369b6732ef9293656dea5d5728ed6c"}},"clinicaltrials-gov-nct03953131-gallium-ga-68-dotatate-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct03953131-gallium-ga-68-dotatate:v1","objectPathId":"clinicaltrials-gov-nct03953131-gallium-ga-68-dotatate-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct03953131-gallium-ga-68-dotatate/","json":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#clinicaltrials-gov-nct03953131-gallium-ga-68-dotatate-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.md#clinicaltrials-gov-nct03953131-gallium-ga-68-dotatate-v1"},"story":{"slug":"clinicaltrials-gov-nct03953131-gallium-ga-68-dotatate","version":1,"domain":"Clinical trials","dateInSource":"2023-09-01","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["gallium-ga-68-dotatate"],"peptides":[{"slug":"gallium-ga-68-dotatate","url":"https://peptidescanner.com/peptides/gallium-ga-68-dotatate/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT03953131","sourceIds":["ctg-observation-nct03953131-2023-09-01-bc7a98d0640d"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT03953131 at 2026-11-16T17:36:42.191Z. Its registry update date was 2023-09-01, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.","sourceIds":["ctg-observation-nct03953131-2023-09-01-bc7a98d0640d"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT03953131 at 2026-11-16T17:36:42.191Z. Its registry update date was 2023-09-01, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.","sourceIds":["ctg-observation-nct03953131-2023-09-01-bc7a98d0640d"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct03953131-2023-09-01-bc7a98d0640d"]}],"sources":[{"id":"ctg-observation-nct03953131-2023-09-01-bc7a98d0640d","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT03953131 · retained source version 2023-09-01:bc7a98d0640d25b0d6d10a04f22c288be67dc31450fb2ffa045f96085b02a311","url":"https://clinicaltrials.gov/study/NCT03953131"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"50a7f6ddd206ae1dd6c11878b9207cbfd14053763eb4ce2aba4f6099252cbdc7","tierARecordSha256":"f82a4ed04de282c36a1f0195b6372c26905ad18953855e6c2fe2d6459256a35f"},"integrity":{"algorithm":"sha256","contentSha256":"55751f7792baff26e17f988bb0e236b90a3fd39d33825eef0410a136d99353be"}},"clinicaltrials-gov-nct04040088-gallium-ga-68-dotatate-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct04040088-gallium-ga-68-dotatate:v1","objectPathId":"clinicaltrials-gov-nct04040088-gallium-ga-68-dotatate-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04040088-gallium-ga-68-dotatate/","json":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#clinicaltrials-gov-nct04040088-gallium-ga-68-dotatate-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.md#clinicaltrials-gov-nct04040088-gallium-ga-68-dotatate-v1"},"story":{"slug":"clinicaltrials-gov-nct04040088-gallium-ga-68-dotatate","version":1,"domain":"Clinical trials","dateInSource":"2026-03-31","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["gallium-ga-68-dotatate"],"peptides":[{"slug":"gallium-ga-68-dotatate","url":"https://peptidescanner.com/peptides/gallium-ga-68-dotatate/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT04040088","sourceIds":["ctg-observation-nct04040088-2026-03-31-cb7158b8edca"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT04040088 at 2026-11-16T17:36:42.191Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.","sourceIds":["ctg-observation-nct04040088-2026-03-31-cb7158b8edca"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT04040088 at 2026-11-16T17:36:42.191Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.","sourceIds":["ctg-observation-nct04040088-2026-03-31-cb7158b8edca"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct04040088-2026-03-31-cb7158b8edca"]}],"sources":[{"id":"ctg-observation-nct04040088-2026-03-31-cb7158b8edca","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT04040088 · retained source version 2026-03-31:cb7158b8edca60e49d6b5f2f98990403cb36fac743df9542c85918cb57e21e05","url":"https://clinicaltrials.gov/study/NCT04040088"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"c088f19b6dcb0f6fb36bd54128ac5c625e79681337d6945a21a1f9464e601664","tierARecordSha256":"9e035c10fab24adf3fa3e15a4ba48bf49d09cbaa6efda8829076a601842e0ca7"},"integrity":{"algorithm":"sha256","contentSha256":"f68ad71995a4f16b5ae49c60345eca8f82a75f30d40f65a7a38f5bc8767b79c6"}},"clinicaltrials-gov-nct04069299-gallium-ga-68-dotatate-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct04069299-gallium-ga-68-dotatate:v1","objectPathId":"clinicaltrials-gov-nct04069299-gallium-ga-68-dotatate-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct04069299-gallium-ga-68-dotatate/","json":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#clinicaltrials-gov-nct04069299-gallium-ga-68-dotatate-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.md#clinicaltrials-gov-nct04069299-gallium-ga-68-dotatate-v1"},"story":{"slug":"clinicaltrials-gov-nct04069299-gallium-ga-68-dotatate","version":1,"domain":"Clinical trials","dateInSource":"2026-03-31","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["gallium-ga-68-dotatate"],"peptides":[{"slug":"gallium-ga-68-dotatate","url":"https://peptidescanner.com/peptides/gallium-ga-68-dotatate/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT04069299","sourceIds":["ctg-observation-nct04069299-2026-03-31-5db2b265cd20"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT04069299 at 2026-11-16T17:36:42.191Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.","sourceIds":["ctg-observation-nct04069299-2026-03-31-5db2b265cd20"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT04069299 at 2026-11-16T17:36:42.191Z. Its registry update date was 2026-03-31, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.","sourceIds":["ctg-observation-nct04069299-2026-03-31-5db2b265cd20"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct04069299-2026-03-31-5db2b265cd20"]}],"sources":[{"id":"ctg-observation-nct04069299-2026-03-31-5db2b265cd20","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT04069299 · retained source version 2026-03-31:5db2b265cd206afe409a159a7d462f6ffaf3b1ce1f467af2c101fe53a8149d5f","url":"https://clinicaltrials.gov/study/NCT04069299"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1134eade072659a56906c1edada1d48c710287e77e1660138e8f093a43208cbc","tierARecordSha256":"12d2341916312afc6db0cd2c323ab36ba8e7f75bad1ee2172bce6fd3dab5d809"},"integrity":{"algorithm":"sha256","contentSha256":"52e212b1ec35d34c1cdca029614b38978ea4a8ed6db92e5c34d72e9a2b1689da"}},"clinicaltrials-gov-nct07150806-gallium-ga-68-dotatate-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:clinicaltrials-gov-nct07150806-gallium-ga-68-dotatate:v1","objectPathId":"clinicaltrials-gov-nct07150806-gallium-ga-68-dotatate-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/clinicaltrials-gov-nct07150806-gallium-ga-68-dotatate/","json":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#clinicaltrials-gov-nct07150806-gallium-ga-68-dotatate-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.md#clinicaltrials-gov-nct07150806-gallium-ga-68-dotatate-v1"},"story":{"slug":"clinicaltrials-gov-nct07150806-gallium-ga-68-dotatate","version":1,"domain":"Clinical trials","dateInSource":"2026-08-13","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["gallium-ga-68-dotatate"],"peptides":[{"slug":"gallium-ga-68-dotatate","url":"https://peptidescanner.com/peptides/gallium-ga-68-dotatate/"}]},"claims":[{"id":"headline","text":"ClinicalTrials.gov record NCT07150806","sourceIds":["ctg-observation-nct07150806-2026-08-13-271a33709bbb"]},{"id":"summary","text":"PeptideScanner retained ClinicalTrials.gov record NCT07150806 at 2026-11-16T17:36:42.191Z. Its registry update date was 2026-08-13, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.","sourceIds":["ctg-observation-nct07150806-2026-08-13-271a33709bbb"]},{"id":"paragraph-1","text":"PeptideScanner retained ClinicalTrials.gov record NCT07150806 at 2026-11-16T17:36:42.191Z. Its registry update date was 2026-08-13, and PeptideScanner's reviewed identity mapping was gallium-ga-68-dotatate.","sourceIds":["ctg-observation-nct07150806-2026-08-13-271a33709bbb"]},{"id":"paragraph-2","text":"This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective.","sourceIds":["ctg-observation-nct07150806-2026-08-13-271a33709bbb"]}],"sources":[{"id":"ctg-observation-nct07150806-2026-08-13-271a33709bbb","name":"ClinicalTrials.gov","sourceClass":"A","title":"ClinicalTrials.gov record NCT07150806 · retained source version 2026-08-13:271a33709bbb9803981c6fa49ba6304ffcb36256532a24adb83a0c2fe52912d0","url":"https://clinicaltrials.gov/study/NCT07150806"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"18c12c37b2fcf79448942141ace3179569c5a2d3b24af4c55bae2fd76a3bbdfd","tierARecordSha256":"f68e1686a52e7c422da1a302680701e3ba5d4d0a9a99d321fae7da687491ced3"},"integrity":{"algorithm":"sha256","contentSha256":"3e30cd69956db03ff245ffed356039d803a5cfb3d734a5fd777178886bb0f650"}},"fda-drugs-nda208547-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:fda-drugs-nda208547:v1","objectPathId":"fda-drugs-nda208547-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/fda-drugs-nda208547/","json":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#fda-drugs-nda208547-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.md#fda-drugs-nda208547-v1"},"story":{"slug":"fda-drugs-nda208547","version":1,"domain":"Regulatory","dateInSource":"2016-06-01","sourceCheckedAt":"2026-11-17","publishedAt":"2026-11-17","peptideSlugs":["gallium-ga-68-dotatate"],"peptides":[{"slug":"gallium-ga-68-dotatate","url":"https://peptidescanner.com/peptides/gallium-ga-68-dotatate/"}]},"claims":[{"id":"headline","text":"Drugs@FDA application NDA208547","sourceIds":["fda-drugs-nda208547-2016-06-01-3d9c9d87d983"]},{"id":"summary","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 208547 with status AP dated 2016-06-01, and names gallium dotatate ga-68 among the application record's active ingredients.","sourceIds":["fda-drugs-nda208547-2016-06-01-3d9c9d87d983"]},{"id":"paragraph-1","text":"The official Drugs@FDA dataset lists original submission 1 for NDA 208547 with status AP dated 2016-06-01, and names gallium dotatate ga-68 among the application record's active ingredients.","sourceIds":["fda-drugs-nda208547-2016-06-01-3d9c9d87d983"]},{"id":"paragraph-2","text":"This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance.","sourceIds":["fda-drugs-nda208547-2016-06-01-3d9c9d87d983"]}],"sources":[{"id":"fda-drugs-nda208547-2016-06-01-3d9c9d87d983","name":"Drugs@FDA via openFDA","sourceClass":"A","title":"Drugs@FDA application NDA208547 · original submission status AP · 2016-06-01 · dataset 2026-11-16","url":"https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA208547%22&limit=1"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ee34034c3cd3e4294710621658d2838b7ba00d11ba23289bdb08695f58dd8145","tierARecordSha256":"3d9c9d87d983ee095a84baeea5d17d26bce92c28da4f789b7c319e49a0a81615"},"integrity":{"algorithm":"sha256","contentSha256":"1546b64bb89c321e478e9e78466c2b07591ff94e18e5856fb9123820dd803128"}},"pubmed-pmid-34096898-gallium-ga-68-dotatate-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-34096898-gallium-ga-68-dotatate:v1","objectPathId":"pubmed-pmid-34096898-gallium-ga-68-dotatate-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-34096898-gallium-ga-68-dotatate/","json":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#pubmed-pmid-34096898-gallium-ga-68-dotatate-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.md#pubmed-pmid-34096898-gallium-ga-68-dotatate-v1"},"story":{"slug":"pubmed-pmid-34096898-gallium-ga-68-dotatate","version":1,"domain":"Literature metadata","dateInSource":"2021-06-16","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["gallium-ga-68-dotatate"],"peptides":[{"slug":"gallium-ga-68-dotatate","url":"https://peptidescanner.com/peptides/gallium-ga-68-dotatate/"}]},"claims":[{"id":"headline","text":"Doing Great With DOTATATE: Update on GA-68 DOTATATE Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging for Evaluation of Sinonasal Tumors.","sourceIds":["pubmed-observation-pmid-34096898-2021-06-16-a122523861a2"]},{"id":"summary","text":"PubMed lists PMID 34096898 in Topics in magnetic resonance imaging : TMRI as Journal Article, Review, with publication-date metadata of 2021-06-01 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-34096898-2021-06-16-a122523861a2"]},{"id":"paragraph-1","text":"PubMed lists PMID 34096898 in Topics in magnetic resonance imaging : TMRI as Journal Article, Review, with publication-date metadata of 2021-06-01 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-34096898-2021-06-16-a122523861a2"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-34096898-2021-06-16-a122523861a2"]}],"sources":[{"id":"pubmed-observation-pmid-34096898-2021-06-16-a122523861a2","name":"PubMed","sourceClass":"A","title":"Doing Great With DOTATATE: Update on GA-68 DOTATATE Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging for Evaluation of Sinonasal Tumors. · retained source version 1:2021-06-16:current:a122523861a2772cbcf64de4e74b63a2c1889761890c47caecb12bb428ece26d","url":"https://pubmed.ncbi.nlm.nih.gov/34096898/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"8daa6eb94db4630d89bb3eb124fb4f6d891fe45e3575b256a173037a8c01e4a7","tierARecordSha256":"7f3edf99952f2636864608a094e5d08d61d8df3be1298c4f0908303ef4e5a42c"},"integrity":{"algorithm":"sha256","contentSha256":"0328bc87add0e0713ecec7dc48c0e3ab21d14be8227306214fd91f203d74cb96"}},"pubmed-pmid-38262470-gallium-ga-68-dotatate-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-38262470-gallium-ga-68-dotatate:v1","objectPathId":"pubmed-pmid-38262470-gallium-ga-68-dotatate-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-38262470-gallium-ga-68-dotatate/","json":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#pubmed-pmid-38262470-gallium-ga-68-dotatate-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.md#pubmed-pmid-38262470-gallium-ga-68-dotatate-v1"},"story":{"slug":"pubmed-pmid-38262470-gallium-ga-68-dotatate","version":1,"domain":"Literature metadata","dateInSource":"2025-02-04","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["gallium-ga-68-dotatate"],"peptides":[{"slug":"gallium-ga-68-dotatate","url":"https://peptidescanner.com/peptides/gallium-ga-68-dotatate/"}]},"claims":[{"id":"headline","text":"Incidental Papillary Thyroid Carcinoma Detected by Ga-68 DOTATATE PET/CT: A Rare Case Study and Clinical Considerations.","sourceIds":["pubmed-observation-pmid-38262470-2025-02-04-429a1ae32de0"]},{"id":"summary","text":"PubMed lists PMID 38262470 in Nuklearmedizin. Nuclear medicine as Case Reports, Journal Article, with publication-date metadata of 2024-01-23 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38262470-2025-02-04-429a1ae32de0"]},{"id":"paragraph-1","text":"PubMed lists PMID 38262470 in Nuklearmedizin. Nuclear medicine as Case Reports, Journal Article, with publication-date metadata of 2024-01-23 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38262470-2025-02-04-429a1ae32de0"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-38262470-2025-02-04-429a1ae32de0"]}],"sources":[{"id":"pubmed-observation-pmid-38262470-2025-02-04-429a1ae32de0","name":"PubMed","sourceClass":"A","title":"Incidental Papillary Thyroid Carcinoma Detected by Ga-68 DOTATATE PET/CT: A Rare Case Study and Clinical Considerations. · retained source version 1:2025-02-04:current:429a1ae32de03b6c58b567cc2466c9b52ce184368fb4a05b364f5f6175c180ae","url":"https://pubmed.ncbi.nlm.nih.gov/38262470/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"a2f9d2544395a35e701bd3d01e3541113ea39142a3c46f145fc8072ed33b608e","tierARecordSha256":"64b33116c462b91d44460ba90ac2ce30207d113fc4254f754ba9da9e23c15ffc"},"integrity":{"algorithm":"sha256","contentSha256":"4259190f49a3e0d57e0eb24ccbad90a6b0e5c2e4b5d8f05703f8fe9fa9f01cbe"}},"pubmed-pmid-38563291-gallium-ga-68-dotatate-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-38563291-gallium-ga-68-dotatate:v1","objectPathId":"pubmed-pmid-38563291-gallium-ga-68-dotatate-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-38563291-gallium-ga-68-dotatate/","json":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#pubmed-pmid-38563291-gallium-ga-68-dotatate-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.md#pubmed-pmid-38563291-gallium-ga-68-dotatate-v1"},"story":{"slug":"pubmed-pmid-38563291-gallium-ga-68-dotatate","version":1,"domain":"Literature metadata","dateInSource":"2024-04-25","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["gallium-ga-68-dotatate"],"peptides":[{"slug":"gallium-ga-68-dotatate","url":"https://peptidescanner.com/peptides/gallium-ga-68-dotatate/"}]},"claims":[{"id":"headline","text":"The lesion detection rate of Ga-68 DOTATATE PET/MR in multiple endocrine neoplasia type 1.","sourceIds":["pubmed-observation-pmid-38563291-2024-04-25-c0670cf437f3"]},{"id":"summary","text":"PubMed lists PMID 38563291 in Journal of medical imaging and radiation oncology as Journal Article, with publication-date metadata of 2024-04-02 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38563291-2024-04-25-c0670cf437f3"]},{"id":"paragraph-1","text":"PubMed lists PMID 38563291 in Journal of medical imaging and radiation oncology as Journal Article, with publication-date metadata of 2024-04-02 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38563291-2024-04-25-c0670cf437f3"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-38563291-2024-04-25-c0670cf437f3"]}],"sources":[{"id":"pubmed-observation-pmid-38563291-2024-04-25-c0670cf437f3","name":"PubMed","sourceClass":"A","title":"The lesion detection rate of Ga-68 DOTATATE PET/MR in multiple endocrine neoplasia type 1. · retained source version 1:2024-04-25:current:c0670cf437f339a0ce9d780ad386096b58a588d32f9e6d4b7ec395a0f9cfc812","url":"https://pubmed.ncbi.nlm.nih.gov/38563291/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"fabac8735d151c1086afa6223dc1eea40fdf80c718e2272d43893f0c42fea8c1","tierARecordSha256":"aeb2a19fcbb07aed0c1822d64a738f4e8bae9ab1c7c7dd31370088cf7369a987"},"integrity":{"algorithm":"sha256","contentSha256":"0da1cff441123f3e1778ac2eea8589ea2e27c8fe8ced2042d1a27812cc4d442a"}},"pubmed-pmid-38933071-gallium-ga-68-dotatate-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-38933071-gallium-ga-68-dotatate:v1","objectPathId":"pubmed-pmid-38933071-gallium-ga-68-dotatate-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-38933071-gallium-ga-68-dotatate/","json":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#pubmed-pmid-38933071-gallium-ga-68-dotatate-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.md#pubmed-pmid-38933071-gallium-ga-68-dotatate-v1"},"story":{"slug":"pubmed-pmid-38933071-gallium-ga-68-dotatate","version":1,"domain":"Literature metadata","dateInSource":"2024-06-28","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["gallium-ga-68-dotatate"],"peptides":[{"slug":"gallium-ga-68-dotatate","url":"https://peptidescanner.com/peptides/gallium-ga-68-dotatate/"}]},"claims":[{"id":"headline","text":"Time-of-Flight PET/CT Imaging of Ga-68-Dotatate: Normal Pattern, SUV Quantification, and Differences from Non-Time-of-Flight Imaging.","sourceIds":["pubmed-observation-pmid-38933071-2024-06-28-5860e73a62eb"]},{"id":"summary","text":"PubMed lists PMID 38933071 in World journal of nuclear medicine as Journal Article, with publication-date metadata of 2024-05-07 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38933071-2024-06-28-5860e73a62eb"]},{"id":"paragraph-1","text":"PubMed lists PMID 38933071 in World journal of nuclear medicine as Journal Article, with publication-date metadata of 2024-05-07 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38933071-2024-06-28-5860e73a62eb"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-38933071-2024-06-28-5860e73a62eb"]}],"sources":[{"id":"pubmed-observation-pmid-38933071-2024-06-28-5860e73a62eb","name":"PubMed","sourceClass":"A","title":"Time-of-Flight PET/CT Imaging of Ga-68-Dotatate: Normal Pattern, SUV Quantification, and Differences from Non-Time-of-Flight Imaging. · retained source version 1:2024-06-28:current:5860e73a62ebed0fd5a96f5583c8417fce114518eb6e97b8f55a92577a19aca8","url":"https://pubmed.ncbi.nlm.nih.gov/38933071/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"6edcb0bfc6a9a4fdce6a5ab62a5c99f3dc22de33e0f20457c21b40c7adcf146c","tierARecordSha256":"380d78e9245780f045d2679741e1eacfc2206fe2cd31bebb3bcb42d772d2aac9"},"integrity":{"algorithm":"sha256","contentSha256":"f24dd3a7af7b9ff15bab8e8aa2476c719b8b7b9f14f785011d782350220faba8"}},"pubmed-pmid-38967895-gallium-ga-68-dotatate-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-38967895-gallium-ga-68-dotatate:v1","objectPathId":"pubmed-pmid-38967895-gallium-ga-68-dotatate-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-38967895-gallium-ga-68-dotatate/","json":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#pubmed-pmid-38967895-gallium-ga-68-dotatate-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.md#pubmed-pmid-38967895-gallium-ga-68-dotatate-v1"},"story":{"slug":"pubmed-pmid-38967895-gallium-ga-68-dotatate","version":1,"domain":"Literature metadata","dateInSource":"2024-11-25","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["gallium-ga-68-dotatate"],"peptides":[{"slug":"gallium-ga-68-dotatate","url":"https://peptidescanner.com/peptides/gallium-ga-68-dotatate/"}]},"claims":[{"id":"headline","text":"Training and assessing convolutional neural network performance in automatic vascular segmentation using Ga-68 DOTATATE PET/CT.","sourceIds":["pubmed-observation-pmid-38967895-2024-11-25-63505f6b2945"]},{"id":"summary","text":"PubMed lists PMID 38967895 in The international journal of cardiovascular imaging as Journal Article, Validation Study, Comparative Study, with publication-date metadata of 2024-07-05 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38967895-2024-11-25-63505f6b2945"]},{"id":"paragraph-1","text":"PubMed lists PMID 38967895 in The international journal of cardiovascular imaging as Journal Article, Validation Study, Comparative Study, with publication-date metadata of 2024-07-05 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-38967895-2024-11-25-63505f6b2945"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-38967895-2024-11-25-63505f6b2945"]}],"sources":[{"id":"pubmed-observation-pmid-38967895-2024-11-25-63505f6b2945","name":"PubMed","sourceClass":"A","title":"Training and assessing convolutional neural network performance in automatic vascular segmentation using Ga-68 DOTATATE PET/CT. · retained source version 1:2024-11-25:current:63505f6b294578739710d9cf36f9e7005f5d3283a49a9e3756d14dce80a07f87","url":"https://pubmed.ncbi.nlm.nih.gov/38967895/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"667de70efe601c21899815a0b8945eccae903a402b2181d0cfdfc4dbdfd6824a","tierARecordSha256":"51ccf2ca4a7a9dcb97996ec11897e8326b8731082ed4a692a65c2e1332874938"},"integrity":{"algorithm":"sha256","contentSha256":"a4cd6f316230372dc887a0de3cefcf4896a10079a34e0da21c2f15e45896b932"}},"pubmed-pmid-42787917-gallium-ga-68-dotatate-v1":{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-42787917-gallium-ga-68-dotatate:v1","objectPathId":"pubmed-pmid-42787917-gallium-ga-68-dotatate-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-42787917-gallium-ga-68-dotatate/","json":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.json#pubmed-pmid-42787917-gallium-ga-68-dotatate-v1","markdown":"https://peptidescanner.com/evidence/v1/peptides/gallium-ga-68-dotatate.md#pubmed-pmid-42787917-gallium-ga-68-dotatate-v1"},"story":{"slug":"pubmed-pmid-42787917-gallium-ga-68-dotatate","version":1,"domain":"Literature metadata","dateInSource":"2026-09-26","sourceCheckedAt":"2026-11-16","publishedAt":"2026-11-16","peptideSlugs":["gallium-ga-68-dotatate"],"peptides":[{"slug":"gallium-ga-68-dotatate","url":"https://peptidescanner.com/peptides/gallium-ga-68-dotatate/"}]},"claims":[{"id":"headline","text":"Pulmonary Metastasis of Grade 1 Meningioma Mimicking a Carcinoid Tumor: A Case Report with FDG PET/CT, Ga-68 DOTATATE PET/CT, and Pathological Confirmation.","sourceIds":["pubmed-observation-pmid-42787917-2026-09-26-a5ba0aa13e40"]},{"id":"summary","text":"PubMed lists PMID 42787917 in World journal of nuclear medicine as Case Reports, Journal Article, with publication-date metadata of 2026-05-05 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42787917-2026-09-26-a5ba0aa13e40"]},{"id":"paragraph-1","text":"PubMed lists PMID 42787917 in World journal of nuclear medicine as Case Reports, Journal Article, with publication-date metadata of 2026-05-05 (day precision). PeptideScanner associated the retained record with the identity slug gallium-ga-68-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-42787917-2026-09-26-a5ba0aa13e40"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-42787917-2026-09-26-a5ba0aa13e40"]}],"sources":[{"id":"pubmed-observation-pmid-42787917-2026-09-26-a5ba0aa13e40","name":"PubMed","sourceClass":"A","title":"Pulmonary Metastasis of Grade 1 Meningioma Mimicking a Carcinoid Tumor: A Case Report with FDG PET/CT, Ga-68 DOTATATE PET/CT, and Pathological Confirmation. · retained source version 1:2026-09-26:current:a5ba0aa13e40e90eb658e40621083b668672c25e1135b17f53e7fe99ec59ddba","url":"https://pubmed.ncbi.nlm.nih.gov/42787917/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"1af7849d5ec80c5e5e71f26b101da816fae398b7783a9c5249437b2082f38d9a","tierARecordSha256":"e25798e23300b73c023f96bd58287bce97a05ad4146ae514c833b5db06631ab7"},"integrity":{"algorithm":"sha256","contentSha256":"d13538197a5cdb7d54df6812d058688b17c4cc39bd5a64f37e5a289af11df65d"}}}}
